Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site

Valuation: Libra Infusions Limited

Capitalization 1.53B 184B 1.45B 1.35B 1.21B 2.15B 130B 2.35B 16.74B 6.23B 53.21B 5.76B 5.63B 231B P/E ratio 2016
131x
P/E ratio 2017 107x
Enterprise value 2.43B 291B 2.3B 2.14B 1.91B 3.4B 205B 3.73B 26.51B 9.87B 84.23B 9.12B 8.92B 365B EV / Sales 2016
6.88x
EV / Sales 2017 6.34x
Free-Float
99%
Yield 2016
0.41%
Yield 2017 0.57%
More valuation ratios * Estimated data
Dynamic Chart
1 day+4.46%
1 week+3.78%
1 month+11.11%
3 months+33.25%
6 months+45.41%
Current year+1.76%
More quotes
1 week
885.00
Extreme 885
955.00
1 month
805.30
Extreme 805.3
958.00
Current year
611.00
Extreme 611
1 125.00
1 year
611.00
Extreme 611
1 125.00
3 years
435.00
Extreme 435
1 146.67
5 years
292.60
Extreme 292.6
1 146.67
10 years
153.61
Extreme 153.6111
1 146.67
More quotes
Director TitleAgeSince
Chief Executive Officer - 1976-02-01
Director of Finance/CFO - -
Comptroller/Controller/Auditor - -
Manager TitleAgeSince
Director/Board Member - 2011-06-20
Chairman - 2013-02-12
Director/Board Member - 2011-06-20
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+4.46%+3.78%-3.02%+86.04%17.59M
+0.91%+6.33%+34.57%+220.65%716B
+1.30%+0.85%+8.89%+114.93%474B
-0.25%-0.10%+0.23%-0.59%373B
-0.08%+3.38%+28.47%+58.68%323B
-1.44%+2.48%-0.82%+35.68%257B
+0.63%+0.47%+8.24%-28.96%233B
-0.12%-0.44%+9.57%+27.00%211B
+0.17%+1.32%+4.80%+28.23%209B
+1.00%-3.96%+4.91%+42.23%152B
Average +0.66%+1.13%+9.58%+58.39% 294.92B
Weighted average by Cap. +0.37%+2.21%+14.83%+85.36%
See all sector performances

Financials

2016 2017
Net sales 238M 28.58B 226M 210M 187M 334M 20.14B 366M 2.6B 968M 8.26B 895M 875M 35.84B 244M 29.31B 232M 215M 192M 342M 20.66B 375M 2.67B 993M 8.47B 918M 897M 36.76B
Net income 5.82M 698M 5.52M 5.13M 4.58M 8.15M 492M 8.94M 63.55M 23.66M 202M 21.87M 21.38M 876M 6.09M 730M 5.77M 5.37M 4.79M 8.53M 515M 9.34M 66.44M 24.74M 211M 22.86M 22.35M 916M
Net Debt 880M 106B 834M 776M 692M 1.23B 74.39B 1.35B 9.6B 3.58B 30.52B 3.3B 3.23B 132B 894M 107B 847M 788M 704M 1.25B 75.62B 1.37B 9.76B 3.63B 31.02B 3.36B 3.28B 135B
More financial data * Estimated data
Logo Libra Infusions Limited
Libra Infusions Ltd is a Bangladesh-based company engaged in manufacturing of Intravenous (I.V.) fluid. The Company's products include LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400 AND LIBRET. Its products are medical necessities used in medical situations involving diarrheal disease, surgical operation, loss of blood, weakness and hospitalization in general. LIBOTT is used for rehydration at the time of water deficit, general weakness and post-surgical intervention. LIBOTT-10 is used for the treatment of jaundice, general weakness, eclampsia and pre-eclampsia. LIBOTT-25 is used in the emergency treatment of severe hypoglycemia. LIBOTT-S is used for rehydration during general weakness, water deficiency along with sodium, diuresis, intoxication and post-surgical intervention. LIBOTT-S JR fulfills water deficit along with low deficiency of sodium chloride and supplies energy for growing children.
Employees
699
More about the company
Date Price Change Volume
24-11-28 936.90 BDT +4.46% 23,669
24-11-27 896.90 BDT -1.56% 13,420
24-11-26 911.10 BDT -2.05% 10,237
24-11-25 930.20 BDT -1.00% 11,828
24-11-24 939.60 BDT +4.08% 23,377

End-of-day quote Dhaka S.E., November 27, 2024

More quotes
  1. Stock Market
  2. Equities
  3. LIBRAINFU Stock
LAST HOURS | BLACK FRIDAY -40%: Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW